Personal testing and a doctor inform dose and schedule
Store the reconstituted vial refrigerated at **28C, protected from light, and use within 28 days**
These studies hold the promise of determining whether similar risk reductions, as observed in type 2 diabetes, can be achieved, offering hope for improved outcomes in this high-risk population

This appointment should include: Complete medication review : Disclose all prescription medications, over-the-counter drugs, and supplements Medical history assessment : Discuss previous mental health treatment, weight management attempts, and relevant conditions Baseline measurements : Blood pressure, weight, BMI, and potentially blood tests (renal function, liver function, HbA1c) Treatment goals : Establish realistic expectations for both depression management and weight loss Contraception discussion : If you're a woman of childbearing age, discuss effective contraception while taking semaglutide During treatment , contact your healthcare provider if you experience: Urgent concerns requiring same-day assessment : Suicidal thoughts or self-harm urges Severe, persistent vomiting or inability to keep fluids down Severe abdominal pain, especially if radiating to the back Signs of allergic reaction (rash, swelling, breathing difficulties) Rapid or irregular heartbeat with chest discomfort Non-urgent issues warranting routine review : Persistent nausea affecting daily activities or nutrition Significant mood changes or increased anxiety Troublesome side effects not improving after 23 weeks Lack of therapeutic response after adequate trial periods Weight loss exceeding recommended rates (approximately 0.51 kg per week) Regular monitoring schedule : For antidepressants, NICE guidance (NG222) recommends review within 24 weeks of initiation (within 1 week for people under 30 or at increased suicide risk), then as clinically indicated
